Stay updated on Dupilumab in COPD Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in COPD Clinical Trial page.

Latest updates to the Dupilumab in COPD Clinical Trial page
- Check4 days agoChange DetectedThe page now displays a 403 Forbidden error. The expected study details and related documents are removed, blocking access to the trial record.SummaryDifference17%

- Check11 days agoChange DetectedRevision label updated to v3.7.0, replacing the previous v3.6.6. This indicates a minor page release/update that does not alter the study details or user-facing content.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedA new NIH grant/contract note from 2018 was added, and a publication by Bhatt et al. on dupilumab in COPD was added to the Publications section. The revision history shows Revision: v3.6.6 and removes v3.6.5.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page shows a new revision tag, updating from v3.6.4 to v3.6.5, indicating an updated version of the page. This update does not modify the study details presented to users.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 on the page, signaling a system-level update to the Study Details interface. This change reflects metadata/version control rather than alteration to the study content or user-visible details.SummaryDifference0.0%

- Check82 days agoChange DetectedThe Publications section now lists the final Chest article (July 2026) for the post hoc analysis of BOREAS and NOTUS, replacing the earlier online-ahead-of-print citation. This update provides final publication details without altering study results or participant information.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in COPD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in COPD Clinical Trial page.